XML 166 R54.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Significant Agreements (Details) - USD ($) |  |  |  |  | 1 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Jul. 29, 2023 | Feb. 01, 2023 | May 21, 2021 | Dec. 31, 2018 | Dec. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2018 | Jul. 21, 2023
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Services payments |  |  |  |  | $ 4,278 |  |  |  |
Assets |  |  |  |  | 87,518,032 | $ 87,518,032 | $ 26,310,447 |  |
Research and development expenses |  |  |  |  |  | 1,949,406 | 4,129,688 |  |
Accounts payable |  |  |  |  | $ 1,800,000 | $ 1,800,000 |  |  |
Accrued expenses |  |  |  |  |  |  | 669,000 |  |
Royalty net sales percentage |  |  |  |  |  | 4.00% |  |  |
Percentage of product |  |  |  |  | 2.00% | 2.00% |  |  |
Royalty rates |  |  |  |  |  |  |  | 25.00% |
Aggregate payments |  |  |  |  |  |  |  | $ 51,250,000 |
Development milestones costs |  |  |  |  |  | $ 500,000 |  |  |
License fee |  |  |  |  |  | 100,000 |  |  |
Total amount of fee expenses | $ 800,000 |  |  |  |  |  |  |  |
Maturity term | Jul. 14, 2025 |  |  |  |  |  |  |  |
Expense related to contract |  |  |  |  |  | 3,100,000 |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Other party payments |  | $ 2,100,000 |  |  |  |  |  |  |
Royalties percentage |  | 2.00% |  |  |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Other party payments |  | $ 4,750,000 |  |  |  |  |  |  |
Royalties percentage |  | 4.00% |  |  |  |  |  |  |
Regulatory milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | 1,250,000 |  |  |
Commercial milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | 58,000,000 |  |  |
Vendor Agreement [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Sales-related services fee |  |  |  |  |  |  |  |  | $ 29,100,000
Ology Bioservices, Inc [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Aggregate agreement amount initial agreement |  |  |  |  |  | 4,000,000 |  |  |
Services payments |  |  |  |  |  | 100,000 |  |  |
Aggregate amount |  |  | $ 2,800,000 |  |  |  |  |  |
Cost plus, percentage |  |  | 15.00% |  |  |  |  |  |
Assets |  |  |  |  | $ 137,000 | 137,000 | 137,000 |  |
Research and development expenses |  |  |  |  |  | 15,000 | 1,329,000 |  |
Accounts payable |  |  |  |  | $ 685,000 | $ 685,000 | $ 476,000 |  |
CHMC Agreement [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Commercial sale term |  |  |  |  |  | 10 years |  |  |
Royalty net sales percentage |  |  |  |  |  | 5.00% |  |  |
Royalty rates |  |  |  |  |  | 50.00% |  |  |
Revenue rate |  |  |  |  |  | 25.00% |  |  |
Option fee |  |  |  |  |  | $ 50,000 |  |  |
Aggregate payments |  |  |  |  |  | $ 59,750,000 |  |  |
Oxford University Innovation Limited [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Royalty net sales percentage |  |  |  |  |  |  |  | 6.00% |
Royalty rates |  |  |  |  |  |  |  | 3.00% |
Royalty payment |  |  |  |  |  |  |  | $ 250,000 |
Maintenance fee |  |  |  |  |  |  |  | 10,000 |
Oxford University Innovation Limited [Member] | Regulatory milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  | $ 9,500,000 |  |  |  |  |
Oxford University Innovation Limited [Member] | Commercial milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  | 39,500,000 |  |  |  |  |
Oxford University Innovation Limited [Member] | Development milestone [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  | $ 2,250,000 |  |  |  |  |
Oxford University Innovation Limited [Member] | OUI Agreement [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Maintenance fee |  |  |  |  |  |  |  | $ 20,000 |
St. Jude Children’s Hospital [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Royalty rates |  |  |  |  |  | 5.00% |  |  |
Aggregate payments |  |  |  |  |  | $ 1,900,000 |  |  |
Percentage of consideration received |  |  |  |  | 15.00% | 15.00% |  |  |
License fee |  |  |  |  |  | $ 5,000 |  |  |
Annual maintenance fee |  |  |  |  |  | 10,000 |  |  |
St. Jude Children’s Hospital [Member] | Regulatory milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | 600,000 |  |  |
St. Jude Children’s Hospital [Member] | Commercial milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | 1,000,000 |  |  |
St. Jude Children’s Hospital [Member] | Development milestone [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | $ 300,000 |  |  |
University of Texas Health Science Center at San Antonio [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Royalty net sales percentage |  |  |  |  |  | 3.00% |  |  |
Royalty rates |  |  |  |  |  | 20.00% |  |  |
Aggregate payments |  |  |  |  |  | $ 2,200,000 |  |  |
University of Texas Health Science Center at San Antonio [Member] | Commercial milestones [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | 1,500,000 |  |  |
University of Texas Health Science Center at San Antonio [Member] | Development milestone [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Development milestones costs |  |  |  |  |  | $ 700,000 |  |  |
University of Texas Health Science Center at San Antonio [Member] | UT Health Agreement [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Royalty net sales percentage |  |  |  |  |  | 5.00% |  |  |
Co Development Agreement [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Research and development expenses |  |  |  |  |  | $ 21,000 |  |  |
Laborator Corporation of America [Member] |  |  |  |  |  |  |  |  |
Significant Agreements [Line Items] |  |  |  |  |  |  |  |  |
Description of licensed products |  |  |  |  |  | • After the first sale of Proclarix as a laboratory developed test, Labcorp will pay an amount in the mid-six figures,• after Labcorp achieves a certain amount in the low seven figures in net sales of Licensed Products, Labcorp will pay Proteomedix an amount in the low seven figures,• after a certain amount in the mid-seven figures in net sales of Licensed Products, Labcorp will pay Proteomedix an amount in the low seven figures. |  |  |

X
- Definition Amount of aggregate Agreement amount initial agreement. + References No definition available. + Details
Name: | onco_AggregateAgreementAmountInitialAgreement
Namespace Prefix: | onco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate royalties amount. + References No definition available. + Details
Name: | onco_AggregateRoyaltiesAmount
Namespace Prefix: | onco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate amount. + References No definition available. + Details
Name: | onco_AggregateeAmount
Namespace Prefix: | onco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow to acquire investments classified as other. + References No definition available. + Details
Name: | onco_AmountOfOtherPartyPayments
Namespace Prefix: | onco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Commercial sale term. + References No definition available. + Details
Name: | onco_CommercialSaleTerm
Namespace Prefix: | onco_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cost plus, percentage. + References No definition available. + Details
Name: | onco_CostPlusPercentage
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of licensed products plus milestone payments. + References No definition available. + Details
Name: | onco_LicensedProductsPlusMilestonePaymentsDescription
Namespace Prefix: | onco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of consideration received. + References No definition available. + Details
Name: | onco_PercentageOfConsiderationReceived
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Revenue rate. + References No definition available. + Details
Name: | onco_RevenueRate
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties percentage. + References No definition available. + Details
Name: | onco_RoyaltiesPercentage
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty net sales. + References No definition available. + Details
Name: | onco_RoyaltyNetSalesPercentage
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty rates. + References No definition available. + Details
Name: | onco_RoyaltyRates
Namespace Prefix: | onco_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(1),(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(15)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 + Details
Name: | us-gaap_AccountsPayableCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1 + Details
Name: | us-gaap_AdministrativeFeesExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(8)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Cost of maintenance incurred and directly related to good produced and service rendered. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_CostMaintenance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_CostOfPropertyRepairsAndMaintenance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the fee that accompanies borrowing money under the debt instrument. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DebtInstrumentFeeAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6 + Details
Name: | us-gaap_DefinedBenefitPlanServiceCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 932 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(7)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1 + Details
Name: | us-gaap_DevelopmentCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(1)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 + Details
Name: | us-gaap_FeeIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maturity date of long-term debt, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_LongTermDebtMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ObligationWithJointAndSeveralLiabilityArrangementLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Rate applied to the undiscounted amount of estimated damages for product liability to arrive at the present value recorded as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.Y.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1 + Details
Name: | us-gaap_ProductLiabilityContingencyAccrualDiscountRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support. + References No definition available. + Details
Name: | us-gaap_ProfessionalAndContractServicesExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of tax expense, excluding income, excise, production and property taxes, and licenses and fees not related to production. + References No definition available. + Details
Name: | us-gaap_TaxesAndLicenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=onco_RegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_CommercialAndIndustrialSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=onco_VendorAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_OlogyBioservicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_CincinnatiChildrensHospitalMedicalCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_OxfordUniversityInnovationLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=onco_DevelopmentMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=onco_OUIAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_StJudeChildrensHospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_UniversityOfTexasHealthScienceCenterAtSanAntonioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=onco_UTHealthAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_CoDevelopmentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=onco_LaboratorCorporationOfAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |